Loading ...

TCO-modified anti-Ki-67 antibody-conjugated tetrazine-modified magneto-fluorescent nanoparticles

Based on

1 Articles
2011 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

trans-cyclooctene-modified anti-EGFR antibody

TCO-modified monoclonal antibody TCO-modified anti-EGFR antibody
Type Biomolecule
Formula
Role raw materials
2

tetrazine-modified magneto-fluorescent nanoparticles

Tz-MFNP
Type Nano Material
Formula
Role graft

Applications

Area Application Nanomaterial Variant Source
diagnostics

More information/entries available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
A431 cells

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  1. DQLMAzcnQtNQR6hLGyxXjm7kFBfj3KNWCoe7BfI58WTKRAtc37KlshZdLAVLh6HmOgCqK8EKPrY99IGDXJ2XTvgtI7PTYHxIGRygqC1ezXJhgGJW8s0P2UXIV8Az31hwzeUA9XT07ZWDAIcMtMnenboZ64sbiTUBTi6Ulekn7wpiHYGgqWIOkyfUeQEVWaEr
Product

TCO-modified anti-Ki-67 antibody-conjugated tetrazine-modified magneto-fluorescent nanoparticles

Size: not specified

Medium/Support: none

Method 2

Type: Chemical synthesis
Source:
Starting materials
Product

TCO-modified anti-Ki-67 antibody-conjugated tetrazine-modified magneto-fluorescent nanoparticles

Size: not specified

Medium/Support: none

Method 3

Type: Chemical synthesis
Source:
Starting materials
  1. 2H9de8McM9Fk0n7m8S1Ns1UPnH2vCNYD83IxfWYYdIV3yeIzQ85pUVBdM09h6xu6TXcShOzt64EoLQprwKqwj6ZPCFrfeZ3bPkgdqrPOI9jvvZRACgNY7G2XbJBMqC0ydRbu2X5a1a9g5JP5zRMC11PrfK1Q9sF27num8td48oNNxGTJ232ecFMzpNA7U5MG
Product

TCO-modified anti-Ki-67 antibody-conjugated tetrazine-modified magneto-fluorescent nanoparticles

Size: not specified

Medium/Support: none

Method 4

Type: Chemical synthesis
Source:
Starting materials
Product

TCO-modified anti-Ki-67 antibody-conjugated tetrazine-modified magneto-fluorescent nanoparticles

Size: not specified

Medium/Support: none

Method 5

Type: Chemical synthesis
Source:
Starting materials
  1. MgcOFrVjAFVay7DQOiOabjYOabomPYz5pswzP3hX9ihHGB1spRd01ebLOMSQi3Scy6AqUEI7taqR7JnfVRcOXyhKe03x0vFI4cHZqAE0bYXqCFFSPsi9IFEX3FIsdIKUqYpbo3mB4Iv02fdCudmJNJqNjfaZpAicuGHexxKN6LkVHjaPW3FatGPQ0z0nBGGL
Product

TCO-modified anti-Ki-67 antibody-conjugated tetrazine-modified magneto-fluorescent nanoparticles

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial